Review
Open access
Aug 2026
Benzothiazole-driven molecular probes and therapeutics for neurodegenerative diseases: focus on amyloid-beta (Aβ), tau, and α-synuclein.
Evidence highlights BZT as one of the most promising privileged scaffolds for integrating early diagnosis, disease monitoring, and disease-modifying intervention within a unified molecular framework for neurodegenerative disorders.
Nitin Kumar, Izhar Khan, Jyoti Singh et al.
· RSC Medicinal Chemistry · 1 citation